Cerebroprotection in the endovascular era: An update

Anna M. Schneider, Robert W. Regenhardt, Adam A. Dmytriw, Aman B. Patel, Joshua Adam Hirsch, Alastair M. Buchan

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

Despite advances in clinical diagnosis and increasing numbers of patients eligible for revascularisation, ischaemic stroke remains a significant public health concern accounting for 3.3 million deaths annually. In addition to recanalisation therapy, patient outcomes could be improved through cerebroprotection, but all translational attempts have remained unsuccessful. In this narrative review, we discuss potential reasons for those failures. We then outline the diverse, multicellular effects of ischaemic stroke and the complex temporal sequences of the pathophysiological cascade during and following ischaemia, reperfusion, and recovery. This evidence is linked with findings from prior cerebroprotective trials and interpreted for the modern endovascular era. Future cerebroprotective agents that are multimodal and multicellular, promoting cellular and metabolic health to different targets at time points that are most responsive to treatment, might prove more successful.

Original languageEnglish
Pages (from-to)267-271
Number of pages5
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume94
Issue number4
DOIs
StatePublished - 1 Apr 2023
Externally publishedYes

Keywords

  • clinical neurology
  • neurosurgery
  • pharmacology
  • stroke

Fingerprint

Dive into the research topics of 'Cerebroprotection in the endovascular era: An update'. Together they form a unique fingerprint.

Cite this